{"name":"Haffkine Bio-Pharmaceutical Corporation Ltd.","slug":"haffkine-bio-pharmaceutical-corporation-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AScVS + Prazosin","genericName":"AScVS + Prazosin","slug":"ascvs-prazosin","indication":"Advanced or metastatic solid tumors (Phase 3 indication under investigation)","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"T.Prazosin","genericName":"T.Prazosin","slug":"t-prazosin","indication":"Hypertension","status":"phase_3"}]}],"pipeline":[{"name":"AScVS + Prazosin","genericName":"AScVS + Prazosin","slug":"ascvs-prazosin","phase":"phase_3","mechanism":"AScVS is an autologous stem cell vaccine that stimulates immune responses against cancer, combined with prazosin, an alpha-1 adrenergic antagonist that may enhance immune function.","indications":["Advanced or metastatic solid tumors (Phase 3 indication under investigation)"],"catalyst":""},{"name":"T.Prazosin","genericName":"T.Prazosin","slug":"t-prazosin","phase":"phase_3","mechanism":"T.Prazosin is an alpha-1 adrenergic receptor antagonist.","indications":["Hypertension","Benign prostatic hyperplasia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPSUYyUFMxME5WSEtqYUFXQXhVbGo2R2FaVTBHbGp1OHRDTmZ2X3RFMkVlaWlKbk1FOTh6eUxhTG04QjNhdUlNM1gtamlXUDdicnR2Ui1qZHAyeDV3TEIzT1p2ZlRUVVdqd21MZGJfNVFHOFJYdnNZNjNwaVBKQ1NwR095N1E?oc=5","date":"2026-02-27","type":"pipeline","source":"The420.in","summary":"Haffkine Leadership Row: Activist Questions Appointment Of GM At State Vaccine Maker Over Corruption Charges - The420.in","headline":"Haffkine Leadership Row: Activist Questions Appointment Of GM At State Vaccine Maker Over Corruption Charges - The420.in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPcG1FWm1rYVNCb2gzN1lLbVByWk9XMEM5dFVBeFlMS1BwdnI4ZGZPNTdTclJRc2ZuNExWbExiNkxoVjVYSHF5aW9Yc0lHSzN0SEppVUZadW5lY3BSMTJ5YjhfLV9UNElvYl9BakdyTk8xZFJZVEVUdWVXdkJRc21DeVMzSk5XZC1xaG52SDVXS1Q1RmNEelRSU09Sa2o0WEh5Yk5wbjh5bkFzdlpHTEkyQ3djajl4N3lfdlVRM3NqZDV1aHlyXy1Jak1BVVd4Zm9xbXZ3MdIB2gFBVV95cUxPdXNwYXNvSEdYYTYzMl8tdTVLQUplQm9rRUlRSU5Pb3JCaUZkOGJTcWRMTnZleENkQUZHS0RVeEQ4VTM4NXhvM3h3SnVMaUxXTC1ZOXg1N1V5dEVBb1pCaU1lR0sycEozY1RzWlpXZ3VzM2hyQ285aWtpUHZtVlN3bWhDaXpfeFVWc1UxQTdmVElrWmxuYzR3bnNsdG1zS3VNdFJyd2tta1FQY2NkTXhyVVgzT0paMkw5YU5PUjE3WlFWTkgyVXV3aE5FVS1DR0ZndnZRUmZmMVh0QQ?oc=5","date":"2026-02-25","type":"pipeline","source":"Hindustan Times","summary":"Backlash over tainted officer getting charge of Haffkine Bio Pharma | Mumbai news - Hindustan Times","headline":"Backlash over tainted officer getting charge of Haffkine Bio Pharma | Mumbai news","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOVENmVzh6UXp4S2pXT3hraDIwWC0zWWNtSG9URjhsWWN4S3NFc0ZYREJ0MHlzcEplbG5hdEVOSmxvRk42UGFTNnZnWXRqbjBoWTlMLVZ2c0RWLUNTRjVtZHRzZks0ZWFFS3NTZWtwQjlnV1ZKSkgxT254VVI5UGdlSEZmLWxhZXN1T0VDZ3hFQTd2dl82aldkTGZVODZsLVF3d2k0SA?oc=5","date":"2026-02-25","type":"pipeline","source":"PUNE PULSE","summary":"Haffkine Bio Pharma Faces Backlash Over Controversial Officer Appointment - PUNE PULSE","headline":"Haffkine Bio Pharma Faces Backlash Over Controversial Officer Appointment","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-26","type":"pipeline","source":"The Times of India","summary":"Haffkine to quiz 2 pharmaceutical firms for selling it ‘blacklisted’ medicines for government hospitals i - The Times of India","headline":"Haffkine to quiz 2 pharmaceutical firms for selling it ‘blacklisted’ medicines for government hospitals i","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOR3dNZThkc0RKMElsQU1rcEtrT3pHb2xtZnk1THhyblZSMTIxQnAxeGVRRkJEQVUtYkxsQVJGUFpoaS1WOXhJU0gwdmpYRkF3SzNFX0xnUjhIQ0FYYjRDMWkzZ1dkTkVVbktPV2w3MGdsMmtsb0JHWVBhVzZ3UU1sS1hHd0dvdVJvdmN3ZEh6aWRxMjIzOGZzTjZvRGR4cnpXMVFxemNiWnZ3dHJaT3R1TTh0NVR2ZmxzUG9JcGYzMXkwMzN1WnlxOVRuZ0RWbFN4QjlUSXlfbUFyd3lDN3dpYXJzTENrUlNDUFE?oc=5","date":"2024-05-29","type":"pipeline","source":"PRWeb","summary":"Haffkine Bio Pharmaceuticals Corporation Ltd., a Leading Government Pharma Manufacturer, Adopts BatchMaster ERP - PRWeb","headline":"Haffkine Bio Pharmaceuticals Corporation Ltd., a Leading Government Pharma Manufacturer, Adopts BatchMaster ERP","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-06-02","type":"pipeline","source":"India TV News","summary":"Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.8 crore doses a year - India TV News","headline":"Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.8 crore doses a year","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-06-02","type":"pipeline","source":"ETV Bharat","summary":"Haffkine Bio-Pharma targets 22.8 crore Covaxin doses a year - ETV Bharat","headline":"Haffkine Bio-Pharma targets 22.8 crore Covaxin doses a year","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-06-02","type":"pipeline","source":"Mumbai Live","summary":"Maharashtra govt grants INR 94 crore for production of Covaxin at Haffkine Bio-Pharma - Mumbai Live","headline":"Maharashtra govt grants INR 94 crore for production of Covaxin at Haffkine Bio-Pharma","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-04-29","type":"pipeline","source":"BusinessLine","summary":"Maharashtra allows Haffkine Bio-Pharma to manufacture Covid vaccines - BusinessLine","headline":"Maharashtra allows Haffkine Bio-Pharma to manufacture Covid vaccines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNbnMtbXpsd0lkeFdvblZMdWh5OEs2dExXNWlvS2tveUFDWWgyS0xVNXlYekNLOFVIMW5jX0FaSEFXbGptOUM2STJkSkZUMElrSXdlYUtSQWNYaTZrRXYyU2RDaUNUYU1Mc2ktU1plYWlhUVhacExiMktFS055VDNJTDVSdWtUVUhEakRycDRKZzdqU3YxUm1wcjI3bXltRHFlSnliTUtkTGxhaW9SZUQ2bGdBczctZw?oc=5","date":"2021-04-16","type":"pipeline","source":"NDTV","summary":"Mumbai's Haffkine Bio-Pharma Targets 22.8 Crore Covaxin Vials A Year - NDTV","headline":"Mumbai's Haffkine Bio-Pharma Targets 22.8 Crore Covaxin Vials A Year","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}